Cargando…
Pembrolizumab-related renal toxicities: diagnosis first, treatment later
Checkpoint inhibitors are increasingly used to treat different types of malignancy and have been associated with renal toxicities. In this issue, Izzedine et al. report on the incidence of pembrolizumab-associated renal toxicity in a French single-centre nephrology referral centre. They report an es...
Autor principal: | Sprangers, Ben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366137/ https://www.ncbi.nlm.nih.gov/pubmed/30746131 http://dx.doi.org/10.1093/ckj/sfy114 |
Ejemplares similares
-
Renal toxicities associated with pembrolizumab
por: Izzedine, Hassan, et al.
Publicado: (2018) -
Azathioprine hypersensitivity syndrome in anti-myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Greite, Robert, et al.
Publicado: (2018) -
Three patients with injection of intravitreal vascular endothelial growth factor inhibitors and subsequent exacerbation of chronic proteinuria and hypertension
por: Hanna, Ramy M, et al.
Publicado: (2018) -
Obesity as a Risk Factor for Radiographic Contrast-Induced
Nephropathy
por: Kabeer, Muhammad Asif, et al.
Publicado: (2020) -
A novel heterozygous mutation in the ATP6V0A4 gene encoding the V-ATPase a4 subunit in an adult patient with incomplete distal renal tubular acidosis
por: Imai, Eri, et al.
Publicado: (2016)